NCT04278768 2026-03-19Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)Curis, Inc.Phase 1/2 Suspended366 enrolled
NCT02718300 2024-05-01A Study of INCB050465 in Combination With Ruxolitinib in Subjects With MyelofibrosisIncyte CorporationPhase 2 Terminated74 enrolled 40 charts